After Hours
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility.
Stocks Info
IONS belongs to the Healthcare sector of the NASDAQ while operating in the Biotechnology industry. The current market capitalization of Ionis Pharmaceuticals Inc is $4.99B. A total of 1.1 million shares were traded on the day, compared to an average of 1.56M shares.
In the most recent transaction, O’NEIL PATRICK R. sold 6,165 shares of IONS for 31.62 per share on Feb 04 ’25. After the transaction, the EVP CLO & General Counsel now owns 57,452 company shares. In a previous transaction on Feb 04 ’25, Monia Brett P sold 38,843 shares at 31.65 per share. IONS shares that Chief Executive Officer owns now total 180,683.
Among the insiders who bought shares, Monia Brett P acquired of 40,003 shares on Feb 04 ’25 at a per-share price of $32.13. In another insider transaction, O’NEIL PATRICK R. bought 7,372 shares at $32.13 per share on Feb 04 ’25.
While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. In terms of 52-week highs and lows, IONS has a high of $52.34 and a low of $31.03.
As of this writing, IONS has an earnings estimate of -$0.84 per share for the current quarter. EPS was calculated based on a consensus of 9.0 estimates, with a high estimate of -$0.7 per share and a lower estimate of -$1.04.
Balance Sheet Annually/Quarterly
An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. IONS’s latest balance sheet shows that the firm has $2.11B in Cash & Short Term Investments as of fiscal 2021. There were $1.25B in debt and $240.55M in liabilities at the time. Its Book Value Per Share was $4.20, while its Total Shareholder’s Equity was $771.74M.
Analysts Opinion
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for IONS is Buy with a score of 4.14.
